Glenn Reicin

Glenn Reicin

Director of Finance/CFO at HARMONY BIOSCIENCES HOLDINGS, INC.
61 year
Finance
Health Technology
Consumer Services

Profile

Glenn M.
Reicin
is Chief Financial Officer at Harmony Biosciences Holdings, Inc. since 2026.
Former roles include Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021; President at Greyrock Biomedical Advisors Ltd. from 2013 to 2019; Director at Novasys Medical, Inc. from 2009 to 2013; Director at SpinalMotion, Inc. from 2009 to 2014; Director at SI-BONE, Inc. from 2010 to 2012; Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008; Managing Director at Skyline Management LLC from 2009 to 2012; Independent Director at Amplitude Healthcare Acquisition Corp.; Analyst at Fidelity Management & Research Co. LLC; Senior Vice President at Oppenheimer & Co., Inc.; Management Consultant at Bain & Co., Inc.; and Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc. Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Glenn Reicin active positions

CompaniesPositionStart
HARMONY BIOSCIENCES HOLDINGS, INC. Director of Finance/CFO 2026-04-13

Former positions of Glenn Reicin

CompaniesPositionEnd
SIGILON THERAPEUTICS, INC. Director of Finance/CFO 2021-06-13
President 2019-04-30
Director/Board Member 2013-12-31
Director/Board Member 2012-12-31
Private Equity Investor 2011-12-31
See the detail of Glenn Reicin's experience

Training of Glenn Reicin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology